{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T02:25:06Z","timestamp":1770776706164,"version":"3.50.0"},"reference-count":49,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,6,17]]},"abstract":"<jats:p>\n            Chronic pulmonary methicillin-resistant\n            <jats:bold>\n              <jats:named-content content-type=\"genus-species\">Staphylococcus aureus<\/jats:named-content>\n            <\/jats:bold>\n            (MRSA) disease in cystic fibrosis (CF) has a high probability of recurrence following treatment with standard-of-care antibiotics and represents an area of unmet need associated with reduced life expectancy. We developed a lipoglycopeptide therapy customized for pulmonary delivery that not only demonstrates potent activity against planktonic MRSA, but also against protected colonies of MRSA both in biofilms and within cells, the latter of which have been linked to clinical antibiotic failure.\n          <\/jats:p>","DOI":"10.1128\/aac.00316-21","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T11:50:02Z","timestamp":1620042602000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":9,"title":["Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections"],"prefix":"10.1128","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-6411","authenticated-orcid":true,"given":"Adam J.","family":"Plaunt","sequence":"first","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasha J.","family":"Rose","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Yeon","family":"Kang","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Ju","family":"Chen","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"LaSala","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan P.","family":"Heckler","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arielle","family":"Dorfman","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barrett T.","family":"Smith","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Chun","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Viramontes","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Macaluso","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhili","family":"Li","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilly","family":"Mark","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Basso","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska G.","family":"Leifer","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel R.","family":"Corboz","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard W.","family":"Chapman","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cipolla","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter R.","family":"Perkins","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir S.","family":"Malinin","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6167-9043","authenticated-orcid":true,"given":"Donna M.","family":"Konicek","sequence":"additional","affiliation":[{"name":"Insmed Incorporated, Bridgewater, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.791"},{"key":"e_1_3_3_3_2","unstructured":"Cystic Fibrosis Foundation. 2018. Cystic Fibrosis Foundation Patient Registry: 2018 annual data report. Cystic Fibrosis Foundation Bethesda MD."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00281-17"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2018.07.005"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01776-19"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.3.841-851.2006"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00766-08"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0891-5520(03)00066-7"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/648438"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2016.11.002"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0505-8"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01642-08"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01093"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ534"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.57.326"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.24139"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature16057"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2014.08.013"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.07.050"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2016.10.001"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.49.575"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2010.71"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-457"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.42.63"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00969"},{"key":"e_1_3_3_27_2","unstructured":"Konicek DM Plaunt AJ Smith BT Heckler RP Chun D Macaluso A Kang J Thaisz J Herr T Gauani H Li Z Chapman RW Corboz MR Perkins WR Malinin VS. 2018. A novel inhaled lipoglycopeptide (RV40) demonstrates high in vivo potency against pulmonary MRSA in a neutropenic rat model abstract ASM Microbe. Atlanta GA."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1456"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.47.7.2283-2292.2003"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl424"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn120"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.8.2853-2860.2004"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2018.08.014"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780471729259.mc01b01s00"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.10.4344-4346.2005"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.04.003"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/1091581815624080"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1164\/arrd.1979.119.3.453"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108703"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2013.09.012"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1086\/590157"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-48-11-1005"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.21.1.114-123.1978"},{"key":"e_1_3_3_44_2","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2018","unstructured":"Clinical and Laboratory Standards Institute. 2018. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard; 11th ed. CLSI standard M07. CLSI, Wayne, PA.","edition":"11"},{"key":"e_1_3_3_45_2","volume-title":"Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2018","unstructured":"Clinical and Laboratory Standards Institute. 2018. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard; 9th ed. CLSI standard M11. CLSI, Wayne, PA.","edition":"9"},{"key":"e_1_3_3_46_2","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2017","unstructured":"Clinical and Laboratory Standards Institute. 2017. Performance standards for antimicrobial susceptibility testing; 29th ed. CLSI supplement M100. CLSI, Wayne, PA.","edition":"29"},{"key":"e_1_3_3_47_2","volume-title":"Methods for determining bactericidal activity of antimicrobial agents; approved guideline","author":"Clinical and Laboratory Standards Institute","year":"1999","unstructured":"Clinical and Laboratory Standards Institute. 1999. Methods for determining bactericidal activity of antimicrobial agents; approved guideline. CLSI document M26-A. CLSI, Wayne, PA."},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00704-15"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00873-17"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1080\/08958370802207318"}],"updated-by":[{"DOI":"10.1128\/aac.01256-22","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000}}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00316-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00316-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:09:42Z","timestamp":1645484982000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00316-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,6,17]]}},"alternative-id":["10.1128\/AAC.00316-21"],"URL":"https:\/\/doi.org\/10.1128\/aac.00316-21","relation":{"correction":[{"id-type":"doi","id":"10.1128\/aac.01256-22","asserted-by":"object"}]},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,17]]},"assertion":[{"value":"2021-02-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00316-21"}}